Anthelmintic Compounds Targeting Methyltransferases

Award Information
Agency: Department of Agriculture
Branch: N/A
Contract: 2004-33610-14303
Agency Tracking Number: 2004-00184
Amount: $80,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Divergence, Inc.
893 North Warson Road, St. Louis, MO, 63141
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Michelle Hresko
 (314) 812-8088
 hresko@divergence.com
Business Contact
 Derek Rapp
Title: Chief Executive Officer
Phone: (314) 812-8052
Email: rapp@divergence.com
Research Institution
N/A
Abstract
The long-term goal of this project is to develop and commercialize anthelmintic drugs to treat nematode infections of animals. Control of parasitic nematode infections in livestock and companion animals is currently dependent on chemical classes discovered more than two decades ago. The economic burden of nematode diseases and the rise of drug-resistant nematodes make it imperative that new effective anthelmintics be brought to market. A significant economic opportunity exists in the area of animal health for the commercialization of novel anthelmintic agents against the most economically important nematode parasites, including Ostertagia in cattle, Haemonchus in sheep, and strongylid infections of horses. Compounds have been identified that target two nematode-specific methyltransferase activities. These enzymes are conserved in many nematodes, play a critical role in the nematode life cycle, and loss of their activity through RNA interference is lethal. The homologous genes are absent from all surveyed vertebrate genomes. More than ten substrate analogs have been identified which are lethal to the free-living nematode C. elegans. The immediate goal of the research is to broaden and improve this family of anthelmintic compounds by designing, synthesizing and testing analogs of the identified inhibitors. Commercially available and newly synthesized compounds will be tested for activity against three free-living nematode species. The most efficacious inhibitors will then be assayed for activity in vitro against animal parasitic nematodes.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government